We are live on ! Find out more
GT

Glenview Trust Portfolio holdings

AUM $6.37B
1-Year Est. Return 23.72%
This Fund
S&P 500
This Quarter Est. Return
-3.7%
1 Year Est. Return
+23.72%
3 Year Est. Return
+87.8%
5 Year Est. Return
+115.86%
10 Year Est. Return
AUM
$5.15B
AUM Growth
-$190M
Cap. Flow
+$81.8M
Cap. Flow %
1.59%
Top 10 Hldgs %
32.96%
Holding
499
New
21
Increased
191
Reduced
199
Closed
25

Top Buys

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$20.4M
2
ACN icon
Accenture
ACN
+$16M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$13.8M
4
BLK icon
Blackrock
BLK
+$13.6M
5
CRM icon
Salesforce
CRM
+$11.5M

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$20.4M
2
SBUX icon
Starbucks
SBUX
+$14.9M
3
EMR icon
Emerson Electric
EMR
+$13.2M
4
EW icon
Edwards Lifesciences
EW
+$12.9M
5
V icon
Visa
V
+$10M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 11.07%
3 Healthcare 10.61%
4 Consumer Discretionary 6.48%
5 Consumer Staples 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ES icon
351
Eversource Energy
ES
$27.3B
$533K 0.01%
8,577
+718
+9% +$42.8K
LH icon
352
Labcorp
LH
$25.6B
$529K 0.01%
2,273
+33
+1% +$8.01K
BN icon
353
Brookfield
BN
$105B
$524K 0.01%
15,009
NNN icon
354
NNN REIT
NNN
$9.02B
$523K 0.01%
12,261
KMI icon
355
Kinder Morgan
KMI
$71.5B
$519K 0.01%
+18,189
New +$504K
JAZZ icon
356
Jazz Pharmaceuticals
JAZZ
$15.9B
$515K 0.01%
4,149
CGMU icon
357
Capital Group Municipal Income ETF
CGMU
$6.36B
$509K 0.01%
18,984
HCA icon
358
HCA Healthcare
HCA
$86.9B
$501K 0.01%
1,451
+32
+2% +$10.3K
INGR icon
359
Ingredion
INGR
$6.29B
$499K 0.01%
3,693
-576
-13% -$76.1K
ELV icon
360
Elevance Health
ELV
$81.9B
$498K 0.01%
1,144
+106
+10% +$42.6K
OEF icon
361
iShares S&P 100 ETF
OEF
$20.1B
$496K 0.01%
1,831
HLT icon
362
Hilton Worldwide
HLT
$72.4B
$492K 0.01%
2,163
-76
-3% -$18.9K
NUE icon
363
Nucor
NUE
$58.7B
$486K 0.01%
4,036
+86
+2% +$11.1K
UNM icon
364
Unum
UNM
$13.6B
$478K 0.01%
5,863
MDY icon
365
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$473K 0.01%
887
-19
-2% -$10.8K
IYC icon
366
iShares US Consumer Discretionary ETF
IYC
$1.17B
$470K 0.01%
5,316
-11,101
-68% -$1.06M
JPST icon
367
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$468K 0.01%
9,238
+2,794
+43% +$141K
STE icon
368
Steris
STE
$22.3B
$460K 0.01%
2,030
-34
-2% -$7.48K
KEYS icon
369
Keysight
KEYS
$55.1B
$460K 0.01%
3,070
+27
+0.9% +$4.46K
VOX icon
370
Vanguard Communication Services ETF
VOX
$5.57B
$450K 0.01%
3,030
-50
-2% -$7.95K
VTR icon
371
Ventas
VTR
$48B
$446K 0.01%
6,485
+1,792
+38% +$114K
VBR icon
372
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.2B
$437K 0.01%
2,348
SLYV icon
373
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
$434K 0.01%
5,541
+26
+0.5% +$2.21K
A icon
374
Agilent Technologies
A
$39.2B
$427K 0.01%
3,646
+1,435
+65% +$193K
EXC icon
375
Exelon
EXC
$47.1B
$423K 0.01%
9,177
+3,646
+66% +$152K

Similar funds

Glenview Trust's Q1 2025 Portfolio in Review

As of Q1 2025, Glenview Trust held 499 positions worth $5.15B, down 3.6% from $5.34B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Glenview Trust's Q1 2025 filing shows 21 new, 191 increased, 199 reduced and 25 closed positions. Its largest new stake was Blackrock: 13,835 shares worth $13.1M. The largest sale was Marvell Technology, an estimated $20.4M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Glenview Trust's largest Q1 2025 buy was Blackrock: 13,835 shares worth $13.1M.
  • Glenview Trust added most to ServiceNow in Q1 2025, an estimated $20.4M increase.
  • Glenview Trust's biggest Q1 2025 reduction was Marvell Technology, cutting an estimated $20.4M.
  • Glenview Trust fully exited iShares US Medical Devices ETF in Q1 2025, selling an estimated $1.1M.
  • Glenview Trust's ten largest holdings make up 33% of its $5.15B portfolio in Q1 2025.
  • Glenview Trust opened 21 new positions and closed 25 in Q1 2025.
  • Glenview Trust's portfolio value fell 3.6% quarter-over-quarter to $5.15B.

Based on Glenview Trust's 13F filing for Q1 2025, filed 15 May 2025.